Q1 2025 Holdings
Filed 2025-05-15 | 67 holdings | $524.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Boston Scientific Corp(BSX) | COM | 101137107 | $33.9M | 336,000 | 6.5% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $31.2M | 1,720,902 | 5.9% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $26.4M | 50,500 | 5.0% |
| CG Oncology Inc(CGON) | COM | 156944100 | $24.0M | 980,942 | 4.6% |
| Humana Inc(HUM) | COM | 444859102 | $21.4M | 81,000 | 4.1% |
| Humana Inc(HUM)Call | COM | 444859102 | $21.2M | 80,000 | 4.0% |
| Natera Inc(NTRA) | COM | 632307104 | $16.9M | 119,200 | 3.2% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $16.1M | 25,400 | 3.1% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $15.3M | 353,000 | 2.9% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $13.9M | 709,517 | 2.6% |
| Glaukos Corp(GKOS) | COM | 377322102 | $13.2M | 134,000 | 2.5% |
| Dexcom Inc(DXCM) | COM | 252131107 | $12.3M | 180,000 | 2.3% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $11.7M | 322,100 | 2.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $11.4M | 925,000 | 2.2% |
| Cencora Inc(COR) | COM | 03073E105 | $10.9M | 39,300 | 2.1% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $9.9M | 80,000 | 1.9% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $9.7M | 72,000 | 1.8% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $9.5M | 85,700 | 1.8% |
| Danaher Corporation(DHR) | COM | 235851102 | $9.1M | 44,500 | 1.7% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $9.0M | 77,000 | 1.7% |
| Genmab A/S(GMAB)Call | SPONSORED ADS | 372303206 | $8.5M | 433,100 | 1.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $8.2M | 107,000 | 1.6% |
| Organon & Co(OGN) | COMMON STOCK | 68622V106 | $8.0M | 535,000 | 1.5% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $7.7M | 15,500 | 1.5% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.7M | 229,000 | 1.5% |
| Spdr SER TR(XBI) | S&P BIOTECH | 78464A870 | $7.6M | 94,000 | 1.5% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $7.6M | 529,000 | 1.4% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $7.5M | 213,000 | 1.4% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $7.4M | 481,000 | 1.4% |
| Avantor Inc(AVTR) | COM | 05352A100 | $7.3M | 453,000 | 1.4% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $7.3M | 445,000 | 1.4% |
| Doximity Inc(DOCS) | CL A | 26622P107 | $7.1M | 122,500 | 1.4% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $7.0M | 258,000 | 1.3% |
| Healthequity Inc(HQY) | COM | 42226A107 | $6.9M | 78,000 | 1.3% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $6.1M | 68,500 | 1.2% |
| Arvinas Inc(ARVN)Call | COM | 04335A105 | $5.3M | 750,000 | 1.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $5.2M | 16,800 | 1.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $5.0M | 800,000 | 1.0% |
| Syndax Pharmaceuticals Inc(SNDX)Call | COM | 87164F105 | $4.9M | 400,000 | 0.9% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $4.9M | 4,454,408 | 0.9% |
| Bruker Corp(BRKR) | COM | 116794108 | $4.8M | 115,000 | 0.9% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $4.7M | 2,197,270 | 0.9% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $4.6M | 7,477,200 | 0.9% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $3.6M | 352,124 | 0.7% |
| Uniqure NV(QURE) | SHS | N90064101 | $3.6M | 336,200 | 0.7% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $3.5M | 145,000 | 0.7% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $2.9M | 413,162 | 0.6% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $2.8M | 169,000 | 0.5% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $2.7M | 87,000 | 0.5% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $2.6M | 75,000 | 0.5% |